In Maryland, scientists have long known that breast cancer stem cells can survive chemotherapy, which is not good as those cells are usually in tumor centers and the ones you really want to get rid of because if they come back, the cancer is often fatal. Scientists found that proteins known as hypoxia-inducible factors (HIFs) are activated when exposed to chemotherapy and they then produce a protein called glutathione-S-transferase O1 (GSTO1) which turns on certain genes that help those nasty breast cancer stem cells survive. The gene expression analysis and experiments conducted in their lab showed that if they can block the HIFs, then the GSTO1 protein is never formed and the breast cancer stem cells couldn’t protect themselves against the chemotherapy, giving much hope for breast cancer patients.
Latest article
UK utility extracting glucose from used TP
In the United Kingdom, water treatment company United Utilities is trialing a process at its Blackburn sewage works to extract glucose from used toilet...
Stella McCartney takes flight with plant-based feathers
In New York, sustainability-focused designer Stella McCartney used faux feathers made from plant-based materials in fashions exhibited at the recent Paris Fashion Week.
Produced...
Artificial Nature hits milestone scaling PLH
In Germany, Artificial Nature S.L. has scaled up production of its biobased and biodegradable copolyester PLH to 300 metric tons per year. The milestone...